[New possibilities in antibacterial treatment of intra-abdominal infections caused by multiresistant microflora]

M D Dibirov1, N N Khachatryan1, A I Isaev1

  • 1Department of Surgery and Clinical Angiology at Moscow State University of Medicine and Dentistry named after A.I. Evdokimov, Moscow, Russia.

Khirurgiia
|December 12, 2019
PubMed
Abstract

Insights

New antibiotics like ceftolozane/tazobactam and ceftazidim/avibactam offer options for treating complicated intra-abdominal infections caused by multidrug-resistant organisms.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Pharmacology

Background:

  • Complicated intra-abdominal infections (cIAIs) pose treatment challenges due to rising antimicrobial resistance.
  • Multidrug-resistant (MDR) pathogens are increasingly implicated in cIAIs.
  • Novel antimicrobial agents are needed to combat MDR infections.

Purpose of the Study:

  • To evaluate the role of new antibiotics against MDR pathogens in cIAIs.
  • To define the potential use of ceftolozane/tazobactam and ceftazidim/avibactam in treating cIAIs.

Main Methods:

  • Analysis of pathogen incidence and distribution in intra-abdominal infections.
  • Review of current antimicrobial resistance trends.
  • Assessment of new drug efficacy against MDR strains.

Main Results:

  • Ceftolozane/tazobactam plus metronidazole shows promise for empiric treatment of cIAIs.
  • Ceftazidim/avibactam plus metronidazole is effective for targeted therapy against carbapenem-resistant Enterobacteriaceae (CRE), including Klebsiella pneumoniae.
  • These agents represent important additions to the therapeutic armamentarium against MDR pathogens in cIAIs.

Conclusions:

  • Ceftolozane/tazobactam with metronidazole can be considered for empiric therapy based on local resistance data.
  • Ceftazidim/avibactam with metronidazole is recommended for targeted therapy of CRE infections due to its high activity and lack of alternatives.

Related Concept Videos

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
205
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
238
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
6.7K
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.0K
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
997
Urine Studies II: Urine Culture and Sensitivity Test01:26

Urine Studies II: Urine Culture and Sensitivity Test

A urine culture and sensitivity test is a diagnostic procedure used to identify urinary tract bacterial infections and determine the most effective antibiotics for treatment. This test is generally preferred when a patient shows manifestations of a urinary tract infection, such as frequent or painful urination, cloudy or foul-smelling urine, or lower abdominal pain.Purpose of the TestThe primary goals of a urine culture and sensitivity test are to:Determine the specific bacteria causing the...
643